Medetomidine Withdrawal Exposes Medical Detox Gaps in US Jails

Medical detox from fentanyl now often means detoxing from two substances at once, and the setting where that happens least safely is a county jail.

Reporting published June 26 by STAT documents what happens when someone withdrawing from medetomidine-laced fentanyl is booked into a facility with no protocol for it.

One woman, identified by a pseudonym because of stigma in her community, was booked into a rural Pennsylvania jail while vomiting and experiencing neurological symptoms severe enough that a corrections officer had to steady her repeatedly to keep her upright. She said she received ibuprofen and an antacid.

Why Medical Detox Matters Here

Medetomidine is a veterinary tranquilizer that began appearing as an adulterant in the illicit opioid supply roughly two years ago. Withdrawal from it can begin within hours of a last dose and can include stroke and heart attack.

That is a meaningful difference from opioid withdrawal, which is severe but not usually directly life threatening. Medetomidine withdrawal frequently requires both oral and intravenous medications, some of them controlled tightly enough that they are available only in intensive care.

The problem is spreading. The CDC reported in April 2026 that medetomidine, sometimes called dex, had been found in drug samples at all 20 of its sentinel sites, with the highest prevalence in the Northeast and the lowest in the West.

What Adequate Treatment Looks Like

Allegheny County Jail in Pittsburgh is the exception in the reporting. Elizabeth Ferro, its director of addiction medicine, worked directly with Michael Lynch, a University of Pittsburgh Medical Center physician researching treatment for medetomidine withdrawal, after she began seeing unusually severe cases.

A second man interviewed for the STAT piece was given lorazepam and phenobarbital at intake there, medications that have sometimes eased symptoms.

He lost consciousness and woke in a hospital days later, having had a heart attack caused by the withdrawal. He was arrested again a week after the interview while withdrawing, had a second heart attack, and died.

That outcome, in one of the better prepared facilities in the country, is the clearest available measure of how dangerous this withdrawal syndrome is.

Why It Goes Undetected

Rapid urine toxicology panels are not designed to detect medetomidine. Emergency physicians often confirm it indirectly, by observing that symptoms persist after medications that would normally bring relief.

Lynch described patients arriving shaky, sweating, and nauseated, with rising heart rate and blood pressure, in a pattern that resembled severe opioid withdrawal but hit harder and faster.

Kevin Fiscella, a University of Rochester physician who helped write withdrawal protocols for US jails, said facilities should consider sending patients in severe withdrawal to a hospital, and should start treatment more aggressively with medications like buprenorphine partly to clarify what they are dealing with.

He noted that many jails already stock clonidine, a blood pressure medication useful in this withdrawal. Ferro added that medetomidine withdrawal often requires considerably higher clonidine doses than usual.

Understanding Medication for Opioid Use Disorder

Buprenorphine and methadone treat both opioid use disorder and opioid withdrawal, because both act on opioid receptors. Naltrexone is a third approved option that works differently. Together these are known as medication for opioid use disorder, and they are the evidence-based standard of care.

Because medetomidine withdrawal nearly always accompanies opioid use disorder, Ferro pointed out that both have to be treated. Facilities already equipped to manage opioid withdrawal are inherently better positioned for this.

Most Jails Are Not Equipped

A national survey of jails conducted after the Department of Justice’s 2022 civil rights guidance found that fewer than half offered any medication for opioid use disorder.

That guidance stated that jails refusing these medications to people who arrive with prescriptions violate the Americans with Disabilities Act. It does not specifically cover people with opioid use disorder who have no existing prescription, which describes most people entering withdrawal at intake.

Funding is a structural obstacle. Federal law prohibits Medicaid from covering medications for people in jail, so costs usually fall to county budgets.

Marcella Alsan, a Harvard physician and economist, co-authored a randomized controlled trial finding that jails adopting National Commission on Correctional Health Care accreditation standards, which require these medications, saw significantly reduced mortality. Accreditation is voluntary.

Finding Medical Detox

Never attempt withdrawal from alcohol or benzodiazepines without medical supervision, as either can cause seizures and death. If fentanyl is involved, assume a sedative adulterant may be present and plan for supervised withdrawal rather than stopping alone.

When contacting a program, ask whether it can manage sedative withdrawal alongside opioid withdrawal, whether it monitors blood pressure and heart rate, whether it starts buprenorphine or methadone during the stay, and what happens at discharge.

Detox.com lists medical detox programs nationwide with detail on levels of care, medications offered, and insurance accepted. Call 800-996-6135(Sponsored) to get in contact with a treatment specialist today.